KR100722155B1 - The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method - Google Patents
The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method Download PDFInfo
- Publication number
- KR100722155B1 KR100722155B1 KR1020060001422A KR20060001422A KR100722155B1 KR 100722155 B1 KR100722155 B1 KR 100722155B1 KR 1020060001422 A KR1020060001422 A KR 1020060001422A KR 20060001422 A KR20060001422 A KR 20060001422A KR 100722155 B1 KR100722155 B1 KR 100722155B1
- Authority
- KR
- South Korea
- Prior art keywords
- chloromandelic acid
- optically active
- chloromandelic
- group
- acid ester
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/005—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of carboxylic acid groups in the enantiomers or the inverse reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/22—Preparation of oxygen-containing organic compounds containing a hydroxy group aromatic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/832—Bacillus
- Y10S435/839—Bacillus subtilis
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/913—Aspergillus
- Y10S435/918—Aspergillus oryzae
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/921—Candida
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
본 발명은 하기 [반응식 1]에서 일반식(1)로 표시되는 라세믹 2-클로로만델릭산 에스테르(2-chloromandelic acid ester)로부터 주요 키랄 중간체로 사용되는 일반식(2)로 표시되는 광학활성 2-클로로만델릭산 에스테르와 일반식(3)으로 표시되는 산을 제조하는 방법에 관한 것이다. 좀 더 상세하게는 수용액상 또는 용매를 포함하는 수용액상에서 반응물인 라세믹 2-클로로만델릭산 에스테르를 가수분해 효소 또는 이를 포함하는 균주를 사용하여 입체선택적으로 가수분해 반응하여 광학활성 2-클로로만델릭산 에스테르와 광학활성 2-클로로만델릭산을 제조하는 방법에 관한 것이다.The present invention provides an optical activity represented by the general formula (2) used as a chiral intermediate from the racemic 2-chloromandelic acid ester represented by the general formula (1) in the following [Scheme 1] A method for producing 2-chloromandelic acid ester and an acid represented by the general formula (3). More specifically, the reaction of the racemic 2-chloromandelic acid ester, which is a reactant in an aqueous solution or an aqueous solution containing a solvent, by stereoselective hydrolysis using a hydrolase or a strain comprising the optically active 2-chloroman The present invention relates to a process for preparing a delic acid ester and an optically active 2-chloromandelic acid.
본 발명은 위에서 언급한 광학활성 2-클로로만델릭산 에스테르 및 산의 제조에 있어서 새로운 방법을 제시하며, 광학순도가 높고 생성물의 제조 및 분리가 용이하여 실제 공정에 유용한 것으로 판단된다.The present invention presents a novel method for the preparation of the above-mentioned optically active 2-chloromandelic acid esters and acids, and is believed to be useful for the actual process due to its high optical purity and ease of preparation and separation of the product.
[반응식1][Scheme 1]
(상기 화합물의 치환체 R은 치환되거나 또는 치환되지 않은 탄소수 1 내지 8의 알킬기 또는 알케닐기, 벤질기, 탄소수 3 내지 6의 싸이클로알킬기, 치환되거나 치환되지 않은 아릴알킬기, 및 치환되거나 치환되지 않은 헤테로아릴알킬기로 이루 어진 군으로부터 선택되어진다.)(Substituent R of the compound is substituted or unsubstituted alkyl group or alkenyl group having 1 to 8 carbon atoms, benzyl group, cycloalkyl group having 3 to 6 carbon atoms, substituted or unsubstituted arylalkyl group, and substituted or unsubstituted heteroaryl It is selected from the group consisting of alkyl groups.)
2-클로로만델릭산, 리파제, 광학활성, 가수분해 반응, 클로피도그렐 2-chloromandelic acid, lipase, optical activity, hydrolysis reaction, clopidogrel
Description
본 발명은 효소 또는 미생물에 의한 광학활성 2-클로로만델릭산 에스테르와 이의 산의 제조방법에 관한 것이다. 좀 더 상세하게는 가수분해 효소 또는 가수분해 효소 생산능을 갖는 미생물을 이용하여 [반응식 1]에서 일반식(1)로 표시되는 라세믹 2-클로로만델릭산 에스테르를 일반식(2)로 표시되는 광학활성 2-클로로만델릭산 에스테르와 일반식(3)으로 표시되는 2-클로로만델릭산으로 가수분해 하는 방법에 관한 것이다.The present invention relates to an optically active 2-chloromandelic acid ester by an enzyme or a microorganism and a method for preparing an acid thereof. More specifically, the racemic 2-chloromandelic acid ester represented by the general formula (1) in [Scheme 1] using a microorganism having a hydrolase or a hydrolase production capacity is represented by the general formula (2). The present invention relates to a method of hydrolyzing an optically active 2-chloromandelic acid ester and 2-chloromandelic acid represented by the general formula (3).
(상기 화합물의 치환체 R은 치환되거나 또는 치환되지 않은 탄소수 1 내지 8의 알킬기 또는 알케닐기, 벤질기, 탄소수 3 내지 6의 싸이클로알킬기, 치환되거나 치환되지 않은 아릴알킬기, 및 치환되거나 치환되지 않은 헤테로아릴알킬기로 이루어진 군으로부터 선택되어진다.)(Substituent R of the compound is substituted or unsubstituted alkyl group or alkenyl group having 1 to 8 carbon atoms, benzyl group, cycloalkyl group having 3 to 6 carbon atoms, substituted or unsubstituted arylalkyl group, and substituted or unsubstituted heteroaryl Is selected from the group consisting of alkyl groups.)
상기에서 언급한 광학활성 2-클로로만델릭산 에스테르는 주요 혈전용해제인 클로피도그렐 바이설파이트((S)-Clopidogrel bisulfate)의 합성에 필요한 키랄 중간체로서 활용범위가 넓다. 토실화 또는 메실화 된 화합물을 무기염 조건하에서 에폭시화하여 다양한 분야의 신약에 적용되는 중요한 의약중간체인 광학활성 2-클로로스틸렌 옥사이드(2-chlorostyrene oxide)로의 전환이 가능하다(대한민국 공개특허 10-2005-0035057). The above-mentioned optically active 2-chloromandelic acid ester is widely used as a chiral intermediate required for the synthesis of clopidogrel bisulfate ((S) -Clopidogrel bisulfate). The tosylated or mesylated compounds can be epoxidized under inorganic salt conditions to be converted into optically active 2-chlorostyrene oxide, which is an important pharmaceutical intermediate applied to new drugs in various fields (Republic of Korea). 2005-0035057).
Noda Hirobumi 등(일본특허 0072644)은 분할제(resolution agent)로 광학활성 N-벤질-2-페닐에틸아민(N-benzyl-1-phenylbutylamine)을 이용하여 라세믹 2-클로로만델릭산으로부터 부분입체이성질체 염(diastereomer salt)를 만들고 산성화하여 (R)-2-클로로만델릭산을 얻었다. 이 공정은 재결정 과정을 필요로 하는 단점이 있다. 비슷한 방법으로 Hyoda Toshiharu 등(일본특허 0114737)은 분할제로 광학활성 알라닌(alanine)을 사용하여 상기 물질을 얻은 바 있다. Noda Hirobumi et al. (Japanese Patent No. 0072644) use diastereomers from racemic 2-chloromandelic acid using optically active N-benzyl-1-phenylbutylamine as a resolution agent. Isomer salts were prepared and acidified to afford (R) -2-chloromandelic acid. This process has the disadvantage of requiring a recrystallization process. In a similar manner, Hyoda Toshiharu et al. (Japanese Patent 0114737) have obtained the material using optically active alanine as a splitting agent.
North michael 등(국제공개특허 00210095)은 키랄 리간드와 키랄 촉매를 사용하여 2-클로로벤즈알데하이드의 시안산화(cyanation)와 아세틸화(acetylation) 과정을 거쳐 (R)-O-아세틸-시아노히드린을 얻고 가수분해하여 (R)-2-클로로만델릭산을 얻었다. 본 방법은 반응을 수행하는 조건이 까다롭고 재결정과정을 여러번 수행해야 한다. North michael et al. (International Patent No. 00210095) use a chiral ligand and a chiral catalyst to undergo cyanation and acetylation of 2-chlorobenzaldehyde to obtain (R) -O -acetyl-cyanohydrin. Obtained and hydrolyzed to obtain (R) -2-chloromandelic acid. This method is difficult to carry out the reaction and requires several recrystallization processes.
한편 효소 및 균주를 이용하는 방법으로는 다음과 같은 방법들이 있다.On the other hand, there are the following methods using the enzyme and strain.
김종근 등(대한민국 공개특허 10-2004-0063264)은 효모(Baker´s yeast)를 이용하여 (R)-2-클로로만델릭산 및 그 에스테르 유도체를 제조하였다. 2-클로로만델릭산으로부터 2-클로로만델레이트 알킬 에스테르 화합물을 제조하고 다시 알킬 2-클로로-벤조일포메이트(Alkyl 2-chloro-benzoylformate)로 합성한 다음, 효모를 이용하여 비대칭 환원 반응(asymmetric reduction)하였다. 메틸 2-클로로-벤조일포메이트, 에틸 2-클로로-벤조일포메이트, 부틸 2-클로로-벤조일포메이트의 경우 4시간 반응 후 각각 전환율 99.9 %, 88.5 %, 99.7% 이었으며 광학순도는 각각 98.45 ee%, 98.5 ee%, 98.4 ee% 의 결과를 보였다. 이 공정은 효모를 이용한 반응 전에 여러번의 합성 단계를 거치는 단점이 있다.Kim, Jong-Keun et al. (Korean Patent Laid-Open Publication No. 10-2004-0063264) prepared (R) -2-chloromandelic acid and ester derivatives thereof by using yeast (Baker's yeast). A 2-chloromandelate alkyl ester compound was prepared from 2-chloromandelic acid and synthesized again with alkyl 2-chloro-benzoylformate, followed by asymmetric reduction using yeast. reduction). In the case of methyl 2-chloro-benzoylformate, ethyl 2-chloro-benzoylformate, and butyl 2-chloro-benzoylformate, the conversion was 99.9%, 88.5%, and 99.7% after 4 hours, respectively, and the optical purity was 98.45 ee%, respectively. , 98.5 ee%, 98.4 ee%. This process has the disadvantage of undergoing several synthetic steps before the reaction with yeast.
엄기남 등(대한민국 공개특허 10-2005-0035057)은 2-클로로만델릭산 에스테르를 제조한 후 유기 용매 상에서 가수 분해 효소를 이용하여 에스테르 반응에 의해 (R)-2-클로로만델릭산 에스테르(100 ee%)와 (S)-2-클로로만델릭 디에스테르로 광학분할 하였다. 하지만 이 공정은 반응 후 각 생성물의 분리가 쉽지 않은 단점을 갖는다.Eom, Ki-Nam et al. (Republic of Korea Patent Publication No. 10-2005-0035057) prepared 2-chloromandelic acid ester and then (R) -2-chloromandelic acid ester (B) by ester reaction using a hydrolytic enzyme in an organic solvent. 100 ee%) and (S) -2-chloromandelic diester were optically divided. However, this process has a disadvantage in that it is not easy to separate each product after the reaction.
Van Langen 등(Organic Process Research & Development, 2003, 7, 828-831)은 2-클로로벤즈알데히드(2-chlorobenzaldehyde)로부터 옥시니트릴라제(oxynitrilase)를 사용하여 2-(2-클로로페닐)-2-히드록시아세토나이트릴(2-(2-chlorophenyl)2-hydroxyacetonitrile)을 제조하고, 다시 산 조건에서 가수분해하고 재결정하여 광학순도 99 ee%의 (R)-2-클로로만델릭산을 제조하였다.Van Langen et al. (Organic Process Research & Development, 2003, 7, 828-831) use 2- (2-chlorophenyl) -2- using oxynitrilase from 2-chlorobenzaldehyde. Hydroxyacetonitrile (2- (2-chlorophenyl) 2-hydroxyacetonitrile) was prepared, and hydrolyzed and recrystallized under acidic conditions to prepare (R) -2-chloromandelic acid having an optical purity of 99 ee%.
이에 본 발명자들은 기존의 보고된 제조 방법 대신에 반응이 간단하며, 생성물의 회수가 쉬운 공정을 개발하고자 하였다. 본 발명에 의한 제조 방법은 가수 분해 효소 또는 이를 포함하는 균주를 이용하여 라세믹 2-클로로만델릭산 에스테르를 가수분해 반응하여 광학활성 2-클로로만델릭산 에스테르와 광학활성 2-클로로만델릭산을 제조하는 방법으로 현재까지 보고된 바가 없는 새로운 공정이다. 또한 본 발명에 의해 제조되는 2-클로로만델릭산 에스테르 및 그의 산은 분리 및 회수가 쉽기 때문에 실제 공정에 유리하게 이용될 수 있다. Thus, the present inventors have attempted to develop a process in which the reaction is simple and the product is easy to recover instead of the previously reported manufacturing method. The production method according to the present invention hydrolyzes racemic 2-chloromandelic acid esters using a hydrolase or a strain comprising the same, thereby optically active 2-chloromandelic acid esters and optically active 2-chloromandelic acid It is a new process that has not been reported so far as a method for preparing. In addition, 2-chloromandelic acid esters and acids thereof prepared according to the present invention can be advantageously used in practical processes because they are easy to separate and recover.
이하 본 발명을 좀 더 구체적으로 살펴보면 다음과 같다. 전술한 바와 같이 본 발명은 라세믹 2-클로로만델릭산 에스테르로부터 가수분해 효소 또는 이를 포함하는 균주를 이용하여 입체선택적으로 가수분해하여 광학활성 2-클로로만델릭산 에스테르와 광학활성 2-클로로만델릭산을 제조하는 방법에 대한 것이다. 또한 반응을 통해 얻어진 광학활성 2-클로로만델릭산 에스테르는 수산화나트륨(NaOH) 등을 사용하여 가수분해하면 광학활성 2-클로로만델릭산으로 전환할 수 있다. Looking at the present invention in more detail as follows. As described above, the present invention is stereoselectively hydrolyzed by using a hydrolase or a strain comprising the same from racemic 2-chloromandelic acid ester, thereby optically active 2-chloromandelic acid ester and optically active 2-chloroman. To a process for preparing delic acid. In addition, the optically active 2-chloromandelic acid obtained through the reaction can be converted to the optically active 2-chloromandelic acid by hydrolysis using sodium hydroxide (NaOH) and the like.
본 발명에 사용되는 효소는 CAL A(노보자임 735),고정화 리파제 CAL B(노보자임 435, Novozyme 사)와 알칼라제(Alcalase), 프로티아제 A(Protease A) 또는 이들 가수분해 효소를 포함하는 균주가 있으나 이에 한정되는 것은 아니다.Enzymes used in the present invention include CAL A (novozyme 735), immobilized lipase CAL B (Novozyme 435, Novozyme) and alcalase, Protease A or these hydrolytic enzymes. There is a strain that is not limited thereto.
본 발명에 있어서, 반응에 사용되는 반응물 및 생성물들은 다음과 같은 조건에서 분석하였다.In the present invention, the reactants and products used in the reaction were analyzed under the following conditions.
라세믹 2-클로로만델릭산 에스테르는 모세관 컬럼인 HP-FFAP(Agilent사)가 장착된 기체크로마토그래피(도남인스트루먼트사, 모델 DS6200)를 이용하여 분석하였다. 100 ℃에서 5 분간 가열 후 220 ℃ 까지 분당 20 ℃씩 올려주고, 220 ℃에서 10 분 동안 유지하였으며, 담체로는 헬륨기체를 사용하였고 컬럼 헤드 압력을 6 psi로 유지하면서 220 ℃에서 FID를 사용하여 검출하였다. 상기 조건에서 메틸 2-클로로만델레이트는 15.31 분, 에틸 2-클로로만델레이트는 14.89 분, 부틸 2-클로로만델레이트는 17.28 분에서 각각 검출되었다.The racemic 2-chloromandelic acid esters were analyzed using gas chromatography (Donan Instruments, Model DS6200) equipped with a capillary column HP-FFAP (Agilent). After heating at 100 ° C. for 5 minutes, the temperature was raised to 220 ° C. by 20 ° C. per minute, and maintained at 220 ° C. for 10 minutes. Helium gas was used as the carrier, and the column head pressure was maintained at 6 psi. Detected. Under these conditions, methyl 2-chloromandelate was detected at 15.31 minutes, ethyl 2-chloromandelate at 14.89 minutes and butyl 2-chloromandelate at 17.28 minutes, respectively.
광학활성 2-클로로만델릭산 에스테르는 키랄 컬럼 AD-H(Daicel 사)가 장착된 HPLC(Lab Aliance사, 모델 201)을 사용하여 분석하였다. 헥산과 이소프로파놀을 90:10의 비율로 혼합하여 분당 0.7 ml로 흘려주었고, UV 흡광도는 220 nm로하여 분석하였다. 이 때 (S)와 (R)-메틸 2-클로로만델레이트는 각각 12.71 분과 13.93 분에서 검출되었고, (S)와 (R)-에틸 2-클로로만델레이트는 각각 12.00 분과 13.95 분에서 검출되었으며, (S)와 (R)-부틸 2-클로로만델레이트는 10.36 분과 12.06 분에서 각각 검출되었다.Optically active 2-chloromandelic acid esters were analyzed using HPLC (Lab Aliance, Model 201) equipped with chiral column AD-H (Daicel). Hexane and isopropanol were mixed at a ratio of 90:10 and flowed at 0.7 ml per minute, and the UV absorbance was analyzed at 220 nm. At this time, (S) and (R) -methyl 2-chloromandelate were detected at 12.71 and 13.93 minutes, respectively, and (S) and (R) -ethyl 2-chloromandelate were detected at 12.00 and 13.95 minutes, respectively. (S) and (R) -butyl 2-chloromandelate were detected at 10.36 and 12.06 minutes, respectively.
이하 실시예를 통하여 본 발명을 좀 더 구체적으로 설명하지만, 하기 예에 본 발명의 범주가 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to Examples, but the scope of the present invention is not limited to the following Examples.
실시예 1. 라세믹 알킬 2-클로로만델레이트의 제조Example 1 Preparation of Racemic Alkyl 2-chloromandelate
메탄올 40 ml에 라세믹 2-클로로만델릭산 2 g을 넣고 35 % 염산 용액을 첨가하여 75 ℃에서 3 시간 반응하였다. 생성물은 중화 후 유기층으로 추출한 뒤 감압 증류를 통해 용매를 제거하여 얻었다. 라세믹 에틸 2-클로로만델레이트와 부틸 2-클로로만델레이트는 메탄올 대신에 에탄올과 부탄올을 각각 사용하여 상기의 조건에서 반응 후 제조하였다. 이에 따라 제조된 생성물은 실리카겔 상에서 정제하고 라세믹 2-클로로만델릭산 에스테르임을 핵자기공명(Burker사, 모델 DRX300)으로 확인하였으며 분석결과는 다음과 같다.2 g of racemic 2-chloromandelic acid was added to 40 ml of methanol, and a 35% hydrochloric acid solution was added thereto and reacted at 75 ° C. for 3 hours. The product was neutralized and extracted with an organic layer, followed by removal of the solvent through distillation under reduced pressure. Racemic ethyl 2-chloromandelate and butyl 2-chloromandelate were prepared after the reaction under the above conditions using ethanol and butanol instead of methanol, respectively. The product thus prepared was purified on silica gel and confirmed to be racemic 2-chloromandelic acid ester by nuclear magnetic resonance (Burker, model DRX300). The analysis results are as follows.
메틸 2-클로로만델레이트Methyl 2-chloromandelate
1H-NMR(CDCl3, 300MHz) δ(ppm)= 3.76(s,3H), 5.57(s,1H), 7.27(m,2H), 7.39(m,2H) 1 H-NMR (CDCl 3 , 300 MHz) δ (ppm) = 3.76 (s, 3H), 5.57 (s, 1H), 7.27 (m, 2H), 7.39 (m, 2H)
에틸 2-클로로만델레이트Ethyl 2-chloromandelate
1H-NMR(CDCl3, 300MHz) δ(ppm)=1.21(t,3H), 4.21(m,2H), 5.54(s,1H), 7.27(m,2H), 7.38(m,2H) 1 H-NMR (CDCl 3 , 300 MHz) δ (ppm) = 1.21 (t, 3H), 4.21 (m, 2H), 5.54 (s, 1H), 7.27 (m, 2H), 7.38 (m, 2H)
부틸 2-클로로만델레이트Butyl 2-chloromandelate
1H-NMR(CDCl3, 300MHz) δ(ppm)=0.83(t,3H), 1.23(m,2H), 1.54(m,2H), 4.16(t,2H), 5.56(s,1H), 7.25(m,2H),7.38(m,2H) 1 H-NMR (CDCl 3 , 300 MHz) δ (ppm) = 0.83 (t, 3H), 1.23 (m, 2H), 1.54 (m, 2H), 4.16 (t, 2H), 5.56 (s, 1H), 7.25 (m, 2H), 7.38 (m, 2H)
실시예 2-3. 가수분해 반응을 통한 광학활성 메틸 2-클로로만델레이트의 제조Example 2-3. Preparation of Optically Active Methyl 2-chloromandelate Through Hydrolysis
0.1 M 인산 완충용액(potassium phosphate buffer, pH 7.0) 5 ml 이 들어있는 바이알에 실시예 1의 방법으로 생성된 라세믹 메틸 2-클로로만델레이트를 1 %(w/v)가 되도록 첨가하고 표 1에 기재된 효소 1 %(w/v)를 사용하여 30 ℃에서 반응을 수행하였다. 일정시간 반응 후 아세트산 에틸로 추출하여 생성물을 상기 분석방법에 따라 분석하였고 그 결과를 표1에 나타내었다.To a vial containing 5 ml of 0.1 M potassium phosphate buffer (pH 7.0), add racemic methyl 2-chloromandelate produced by the method of Example 1 to 1% (w / v) and The reaction was carried out at 30 ° C. using 1% (w / v) of the enzyme described in 1. After a certain reaction, the product was extracted with ethyl acetate and analyzed according to the above analysis method. The results are shown in Table 1.
실시예 4-7. 가수분해 반응을 통한 광학활성 에틸 2-클로로만델레이트의 제조Example 4-7. Preparation of optically active ethyl 2-chloromandelate via hydrolysis reaction
실시예 2에서 반응물로 사용된 메틸 2-클로로만델레이트 대신에 에틸 2-클로로만델레이트를 사용하여 표 2에 기재된 효소를 이용하여 반응하고 그 결과는 다음과 같다.Instead of methyl 2-chloromandelate used as a reactant in Example 2 using ethyl 2-chloromandelate using the enzymes listed in Table 2 and the results are as follows.
실시예 8. 가수분해 반응을 통한 광학활성 부틸 2-클로로만델레이트의 제조Example 8. Preparation of Optically Active Butyl 2-Chloromandelate Through Hydrolysis Reaction
실시예 2에서 반응물로 사용된 메틸 2-클로로만델레이트 대신에 부틸 2-클로로만델레이트를 사용하고 CAL B로 48 시간 반응하여 전환율 93.1 % 일 때, 광학순도 76.0 ee%를 갖는 부틸 (R)-클로로만델레이트를 제조하였다.Butyl (R) having an optical purity of 76.0 ee% when the conversion rate was 93.1% using butyl 2-chloromandelate instead of methyl 2-chloromandelate used as a reactant in Example 2 and reacting with CAL B for 48 hours. ) -Chloromandelate was prepared.
실시예 9. 광학활성 (R)-2-클로로만델릭산의 제조Example 9 Preparation of Optically Active (R) -2-chloromandelic Acid
라세믹 에틸 2-클로로만델레이트를 실시예 6에서 사용된 CAL B를 사용하여 가수분해 반응에 의해 광학순도 99 ee%의 에틸 (R)-2-클로로만델레이트로 얻었다. 회수한 에틸 (R)-2-클로로만델레이트를 메탄올에 녹이고 10 %(w/v) 수산화나트륨 용액을 첨가한 후 상온에서 충분히 반응한 후, 반응액을 염산 용액을 이용하여 pH 1로 조절하고 t-부틸 메틸에스테르(t-BME)를 사용하여 생성물로 흰색 고체를 수득하였다. 분석결과 광학순도 99 ee%의 (R)-2-클로로만델릭산임을 확인하였다. Racemic ethyl 2-chloromandelate was obtained by hydrolysis reaction with CAL B used in Example 6 as ethyl (R) -2-chloromandelate of optical purity 99 ee%. The collected ethyl (R) -2-chloromandelate was dissolved in methanol, 10% (w / v) sodium hydroxide solution was added, and then sufficiently reacted at room temperature. The reaction solution was then adjusted to pH 1 using hydrochloric acid solution. And t-butyl methyl ester (t-BME) to give a white solid as a product. The analysis results confirmed that the optical purity was 99 ee% (R) -2-chloromandelic acid.
상기 실시예 2-9을 통해 알 수 있는 것과 같이, 광학활성 2-클로로만델릭산 에스테르를 제조하는 방법에 있어서 본 발명에 따른 가수분해 반응은 반응이 용이하고, 높은 광학순도의 생성물을 얻을 수 있다. 또한 반응 후 각각의 광학활성 에스테르와 2-클로로만델릭산의 회수가 용이하여 산업적으로 대량생산에 적절한 제조 공정이다. As can be seen through Example 2-9, in the method for preparing the optically active 2-chloromandelic acid ester, the hydrolysis reaction according to the present invention is easy to react, it is possible to obtain a product of high optical purity have. In addition, it is easy to recover each optically active ester and 2-chloromandelic acid after the reaction is a suitable manufacturing process for industrial mass production.
Claims (2)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060001422A KR100722155B1 (en) | 2006-01-05 | 2006-01-05 | The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method |
PCT/KR2007/000085 WO2007078176A1 (en) | 2006-01-05 | 2007-01-05 | The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020060001422A KR100722155B1 (en) | 2006-01-05 | 2006-01-05 | The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method |
Publications (1)
Publication Number | Publication Date |
---|---|
KR100722155B1 true KR100722155B1 (en) | 2007-05-28 |
Family
ID=38228460
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020060001422A KR100722155B1 (en) | 2006-01-05 | 2006-01-05 | The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR100722155B1 (en) |
WO (1) | WO2007078176A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102206686B (en) * | 2011-04-19 | 2013-06-26 | 华东理工大学 | Preparation method of methyl (R)-o-chloromandelate utilizing biocatalytic asymmetric reduction |
CN108192932B (en) * | 2017-12-26 | 2020-09-29 | 上海皓元生物医药科技有限公司 | Enzyme catalysis preparation method of chiral alcohol |
CN111118073B (en) * | 2019-12-27 | 2022-02-15 | 宜昌东阳光生化制药有限公司 | Method for synthesizing intermediate of ezetimivir by enzyme method |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001072644A (en) | 1999-09-06 | 2001-03-21 | Yamakawa Yakuhin Kogyo Kk | Production of optically active 2-chloromandelic acid and production intermediate |
JP2002114737A (en) | 2000-10-11 | 2002-04-16 | Japan Hydrazine Co Inc | METHOD FOR PRODUCING OPTICALLY ACTIVE o-CHLOROMANDELIC ACID |
EP1382674A2 (en) | 2002-07-16 | 2004-01-21 | Daicel Chemical Industries, Ltd. | Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same |
KR20040063264A (en) * | 2003-01-06 | 2004-07-14 | 에스케이 주식회사 | Method for preparing optically active (R)-2-chloromandelic acid and its ester derivatives using Baker's Yeast |
KR20050035057A (en) * | 2003-10-11 | 2005-04-15 | 주식회사 아이디알 | Process for (r) or (s)-2-chlorostyrene oxide by using enzyme |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2720140B2 (en) * | 1993-02-03 | 1998-02-25 | 日東化学工業株式会社 | Method for producing optically active α-hydroxycarboxylic acid having phenyl group |
-
2006
- 2006-01-05 KR KR1020060001422A patent/KR100722155B1/en not_active IP Right Cessation
-
2007
- 2007-01-05 WO PCT/KR2007/000085 patent/WO2007078176A1/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001072644A (en) | 1999-09-06 | 2001-03-21 | Yamakawa Yakuhin Kogyo Kk | Production of optically active 2-chloromandelic acid and production intermediate |
JP2002114737A (en) | 2000-10-11 | 2002-04-16 | Japan Hydrazine Co Inc | METHOD FOR PRODUCING OPTICALLY ACTIVE o-CHLOROMANDELIC ACID |
EP1382674A2 (en) | 2002-07-16 | 2004-01-21 | Daicel Chemical Industries, Ltd. | Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same |
KR20040063264A (en) * | 2003-01-06 | 2004-07-14 | 에스케이 주식회사 | Method for preparing optically active (R)-2-chloromandelic acid and its ester derivatives using Baker's Yeast |
KR20050035057A (en) * | 2003-10-11 | 2005-04-15 | 주식회사 아이디알 | Process for (r) or (s)-2-chlorostyrene oxide by using enzyme |
Also Published As
Publication number | Publication date |
---|---|
WO2007078176A1 (en) | 2007-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS63273499A (en) | Production of optically active compound | |
KR100722155B1 (en) | The method of making optically active 2-chloromandelic acid esters and 2-chloromandelic acids by enzymatic method | |
KR100846676B1 (en) | The method of making optically active 2-halo-2-n-substituted phenylacetic acid esters and 2-halo-2-n-substituted phenylacetic acids by enzymatic method | |
EP1290209B1 (en) | Method for preparing an r- or s-form of alpha-substituted heterocyclic carboxylic acid and a counter enantiomeric form of alpha-substituted heterocyclic carboxylic acid ester thereto using enzyme | |
KR100758512B1 (en) | The method of preparing optically active 3-hydroxy-3-phenylpropionic acids and optically active 3-acyloxy-3-phenylpropionic acid by enzymatic method | |
EP1290208B1 (en) | Method for optically resolving a racemic alpha-substituted heterocyclic carboxylic acid using enzyme | |
EP0512848A2 (en) | Enzymatic resolution of alpha-tertiary carboxylic acid esters | |
KR100657204B1 (en) | The method of making optically active 3-hydroxy-?-butyrolactone by enzymatic method | |
CA2145230A1 (en) | Enzymatic resolution of asymmetric alcohols by means of vinyl esters of polybasic carboxylic acids | |
KR100368735B1 (en) | Method for preparing R- or S-form α-substituted heterocyclic carboxyl acid using enzyme | |
KR100973710B1 (en) | The method for preparing optically active n-substituted phenylglycine alkyl esters by enzymatic method | |
KR100395310B1 (en) | Method for optically resolving preparing R- or S-form α-substituted heterocyclic carboxyl acid using enzyme | |
KR100650798B1 (en) | Process for preparing chiral substituted carboxylic acid | |
KR100846674B1 (en) | The method of preparing optically active trans-alcohols and their esters by enzymatic method | |
JP2007117034A (en) | Method for producing optically active nipecotic acid compound | |
JP3583798B2 (en) | Method for producing optically active 2-methylbutanoic acid and derivatives thereof | |
KR100651393B1 (en) | Mothod for preparing R-1-amino-2-propanol using hydrolysis enzyme | |
WO2007035066A1 (en) | The method of making optically active 3-acyloxy-gamma-butyrolactone and optically active 3-hydroxy-gamma-butyrolactone by enzymatic method | |
JP2609922B2 (en) | 2'-Ketopantothenic acid ester | |
KR100748897B1 (en) | The method of making optically active 3-hydroxybutyric acid and their esters by enzymatic method | |
JP2008271827A (en) | METHOD FOR PRODUCING OPTICALLY ACTIVE N-ARYL-beta-AMINO ACID COMPOUND | |
KR20100116727A (en) | A method for preparing opically active alcoholic compounds derivatives | |
JPH10248592A (en) | Production of optically active 2-benzylsuccinic acid and its derivative | |
KR20040071452A (en) | The method of making optically active ethyl 3-hydroxy-3-phenylpropionate and their esters by enzymatic method | |
JP2009263341A (en) | Method of manufacturing optically active nipecotic acid ester derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
J201 | Request for trial against refusal decision | ||
B701 | Decision to grant | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121121 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20130618 Year of fee payment: 7 |
|
LAPS | Lapse due to unpaid annual fee |